A drug currently used to treat leukaemia might also help prevent breast cancer from spreading to other parts of the body, suggests an animal study in the open-access journal Breast Cancer Research. The discovery could also pave the way for improved early diagnostics. Peter Storz and colleagues...
New positive Phase II results from an interim analysis of the randomised Phase I/II study involving the company's investigational haematology/oncology compound volasertib* in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction...
Researchers have discovered a gene that when mutated can cause lymphoedema (swollen limbs due to a failure of the lymph system), immune abnormalities, deafness and leukaemia. The identification of the gene responsible for causing this rare combination of medical conditions, known as Emberger...
In new draft guidance, published today, NICE has not been able to recommend dasatinib, high-dose imatinib or nilotinib for the treatment of CML (chronic myeloid leukaemia) that is resistant to standard-dose imatinib. In response to the draft guidance Andrew Dillon, Chief Executive at NICE, said...